The Benefits of Public Advisory Committees at the FDA
More committees with less conflicted members may increase regulatory safety.
Is the Rulemaking Process Really a Quagmire?
Scholars laud rulemaking’s efficiency, noting it takes “remarkably little time.”
Week in Review
Supreme Court declines to halt temporarily the contraceptive coverage rule, FTC toughens child online privacy rule, and more.
The Regulatory Blame Game
Criticism of FDA over meningitis outbreak repeats a familiar pattern of regulatory blame.
Week in Review
Political leaders call for stronger gun regulation, FDA chief pushes for specialty pharmacy rules, and more.
Week in Review
British Petroleum agrees to billion-dollar oil spill settlement, FDA asks for legislation on compounding pharmacies, and more.
FDA Further Appeals Loss over Graphic Tobacco Packages Regulation
Agency seeks further review of lower court decision on graphic warnings rule.
Week in Review
Legislators seek answers on meningitis outbreak, business groups sue SEC over Dodd-Frank disclosure rule, and more.
Week in Review
White House group requests speedier drug approval, report details advantages of carbon tax, and more.